Evaluation of the Efficiency of Bone Born Intra Oral Distractor for Closure of Wide Alveolar Cleft
NCT ID: NCT07306429
Last Updated: 2025-12-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
8 participants
INTERVENTIONAL
2023-03-14
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bone-Borne Intra-oral distractor
Surgeries to fix the device were conducted under GA. Then latency period of seven days was applied. Activation was 0.5 mm twice a day. The transport segment touched the docking site then the Consolidation period is achieved. Follow up for 6 months.
Bone-borne Intra oral distractor
Evaluation of the efficiency of the Bone-Borne Intraoral distractors on wide Alveolar cleft
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bone-borne Intra oral distractor
Evaluation of the efficiency of the Bone-Borne Intraoral distractors on wide Alveolar cleft
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who had previous failed grafting also may be included.
* Age range of patients 7-20 years old, with no gender prediction, able to read and sign the informed consent (parents)
* Patients with median facial clefts.
Exclusion Criteria
* Syndromic patients.
* Oral soft tissues defects, inflammation, infections and bone metabolism disturbance.
* Allergy to titanium implant.
* Patient with systemic disease and immunocompromised patient.
7 Years
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Faculty of Dental Medicine for Girls
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hanaa Elmorsy
Assistant Lecturer at Oral and Maxillofacial Surgery department at AlAzhar University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hanaa Elmorsy, Assis.Lec
Role: STUDY_CHAIR
Assistant lecturer of OMFs department Azhar University
Susan H Abdel Hakim, professor
Role: STUDY_DIRECTOR
Professor of OMFs department azhar university
Wael Shawkat, Consultant
Role: STUDY_DIRECTOR
Head of the department at the Health Insurance Hospital
Fatema khalifa, Assist.Prof
Role: STUDY_DIRECTOR
Assistant Professor of OMFs Azhar university
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of oral and dental medicine for Girls AlAzhar University
Cairo, Cairo Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ORSUR-10
Identifier Type: -
Identifier Source: org_study_id